Skip to content

Drug interactions

Ledipasvir-sofosbuvir + Topotecan

Severity: Major

Ledipasvir-sofosbuvir and Topotecan: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ledipasvir may increase topotecan exposure, particularly oral topotecan, raising the risk of myelosuppression and gastrointestinal toxicity.

What this interaction means in plain words

Ledipasvir-sofosbuvir and Topotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ledipasvir-sofosbuvir belongs to Anti Virals; Topotecan belongs to Oncology.

Evidence level: Low

Why it happens

Ledipasvir inhibits P-gp and possibly BCRP, increasing topotecan absorption and reducing its elimination.

What to do

Avoid with oral topotecan; with IV topotecan, monitor blood counts closely and consider dose reduction.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ledipasvir-sofosbuvir and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ledipasvir-sofosbuvir with Topotecan?

MediHelp rates the interaction as major. Ledipasvir-sofosbuvir and Topotecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ledipasvir may increase topotecan exposure, particularly oral topotecan, raising the risk of myelosuppression and gastrointestinal toxicity.

How serious is the interaction between Ledipasvir-sofosbuvir and Topotecan?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid with oral topotecan; with IV topotecan, monitor blood counts closely and consider dose reduction.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in